Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity

被引:0
|
作者
Jian-Ting Zhang
机构
[1] Walther Oncology Center/Walther Cancer Institute and IU Cancer Center,Department of Pharmacology and Toxicology
[2] Indiana University School of Medicine,undefined
来源
Cell Research | 2007年 / 17卷
关键词
genomics; MDR; drug resistance; ABC transporter; microarray; real time quantitative PCR;
D O I
暂无
中图分类号
学科分类号
摘要
Multidrug resistance (MDR) is a major problem in cancer chemotherapy. One of the best known mechanisms of MDR is the elevated expression of ATP-binding cassette (ABC) transporters. While some members of human ABC transporters have been shown to cause drug resistance with elevated expression, it is not yet known whether the over-expression of other members could also contribute to drug resistance in many model cancer cell lines and clinics. The recent development of microarrays and quantitative PCR arrays for expression profiling analysis of ABC transporters has helped address these issues. In this article, various arrays with limited or full list of ABC transporter genes and their use in identifying ABC transporter genes in drug resistance and chemo-sensitivity prediction will be reviewed.
引用
收藏
页码:311 / 323
页数:12
相关论文
共 50 条
  • [41] Acquired AKT-inhibitor Resistance Is Mediated by ATP-binding Cassette Transporters in Endometrial Carcinoma
    Takagi, Shoji
    Onishi, Takafumi
    Takashima, Tsuyoshi
    Shibahara, Kazuki
    Mori, Michihiro
    ANTICANCER RESEARCH, 2023, 43 (06) : 2501 - 2507
  • [42] Multiple ATP-binding cassette transporters genes are involved in thiamethoxam resistance in Aphis gossypii glover
    Pan, Yiou
    Zeng, Xiaochun
    Wen, Shuyuan
    Gao, Xiwu
    Liu, Xuemei
    Tian, Fayi
    Shang, Qingli
    PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 2020, 167
  • [43] Multidrug resistance ATP-binding cassette membrane transporters as targets for improving oropharyngeal candidiasis treatment
    Martinez, Lorena
    Falson, Pierre
    ADVANCES IN CELLULAR AND MOLECULAR OTOLARYNGOLOGY, 2014, 2 (01):
  • [44] ALTERATIONS OF CANALICULAR ATP-BINDING CASSETTE TRANSPORTERS IN PATIENTS WITH DRUG-INDUCED LIVER INJURY
    Zollner, G.
    Thueringer, A.
    Lackner, C.
    Fickert, P.
    Trauner, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S449 - S449
  • [45] Multidrug resistance-related ATP-binding cassette (ABC) transporters in dendritic cell functions
    Van de Ven, Rieneke
    De Jong, Mariska C.
    Reurs, Anneke W.
    Schoonderwoerd, Antoinet J.
    Jansen, Gerrit
    Hooijberg, Jan H.
    Scheffer, George L.
    De Gruijl, Tanja D.
    Scheper, Rik J.
    CANCER RESEARCH, 2006, 66 (08)
  • [46] ATP-BINDING CASSETTE (ABC) TRANSPORTERS ARE STILL IMPORTANT DRUG TARGETS FOR COMBATING MULTIDRUG-RESISTANT CANCER CELLS
    Sgaragli, Giampietro
    ANTICANCER RESEARCH, 2014, 34 (10) : 6160 - 6162
  • [47] Protection against chemotherapy-induced alopecia: targeting ATP-binding cassette transporters in the hair follicle?
    Haslam, Iain S.
    Pitre, Aaron
    Schuetz, John D.
    Paus, Ralf
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (11) : 599 - 604
  • [48] Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance
    Revalde, Jezrael L.
    Li, Yan
    Hawkins, Bill C.
    Rosengren, Rhonda J.
    Paxton, James W.
    BIOCHEMICAL PHARMACOLOGY, 2015, 93 (03) : 305 - 317
  • [49] How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?
    Jaramillo, Adrian C.
    Al Saig, Farah
    Cloos, Jacqueline
    Jansen, Gerrit
    Peters, Godefridus J.
    CANCER DRUG RESISTANCE, 2018, 1 (01) : 6 - 29
  • [50] The Role of Specific ATP-Binding Cassette Transporters in the Acquired Resistance to Pyrrolobenzodiazepine Dimer-Containing Antibody-Drug Conjugates
    Corbett, Simon
    Huang, Shiran
    Zammarchi, Francesca
    Howard, Philip W.
    van Berkel, Patrick H.
    Hartley, John A.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (09) : 1856 - 1865